Navigation Links
Novavax Licenses Recombinant VLP Influenza Vaccine to LG Life Sciences for South Korea and Other Countries
Date:2/28/2011

ROCKVILLE, Md., Feb. 28, 2011 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) announced today an agreement to license its proprietary, recombinant virus-like-particle (VLP) vaccine technology to LG Life Sciences, Ltd. (LGLS). Under the agreement, LGLS receives an exclusive license to manufacture, develop and commercialize influenza vaccines using Novavax's recombinant VLP technology in South Korea. LGLS also receives a non-exclusive license to manufacture, develop and commercialize influenza VLP vaccines in certain emerging market countries.

LGLS will be responsible for funding clinical development and licensure of influenza VLP vaccines in South Korea and other countries, and for construction of a new VLP vaccine manufacturing facility planned at LGLS's Osong campus in South Korea.  Novavax will receive upfront and milestone payments from LGLS in addition to double-digit royalty rate payments from commercial sales. Novavax will provide VLP technology transfer and manufacturing support for LGLS's new vaccine production facility.

Dr. Rahul Singhvi, CEO and President of Novavax, stated: "LGLS is an affiliate of LG, a global conglomerate. LGLS is a leading provider of vaccines to supranational health organizations such as UNICEF and the Pan American Health Organization (PAHO). We welcome this opportunity to develop a recombinant influenza vaccine solution for South Korea and other countries served by LGLS.  This new partnership with LGLS is further validation of our VLP technology and, as we have done previously with our joint venture in India with Cadila Pharmaceuticals, further expands our development efforts into new territories. LGLS will help us advance our technology in Korea and other countries, consistent with our commercial strategy of developing regional partnerships and in-country manufacturing solutions with leading pharmaceutical companies around the w
'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
2. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
4. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
5. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
6. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
7. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
8. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
9. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 3, 2015 Un fournisseur ... que sont l,hypertension, le diabète et les troubles ... éducatives gratuites et d,une conférence majeure dédiée à ... ) , Les formations ... Prendre en charge l,hypertension en ligne ...
(Date:7/2/2015)... -- Pharma Major Lupin Limited anunció ... ZAO "Biocom" en Rusia bajo ciertas condiciones de ... en el mercado farmacéutico de Rusia que registró ... uno de los 10 principales mercados farmacéuticos del ... una década, el mercado farmacéutico ruso registró un ...
(Date:7/2/2015)... N.C. , July 2, 2015  New product ... of its leading role in educating thought leaders about ... that can heavily influence how well a new therapy ... new study from research and consulting leader Best Practices, ... leaders need to focus on are early stage thought ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2
... Not for release, publication or distribution, in whole or in ... where to do so would constitute a violation of the relevant laws ... BY ALERE AS HOLDINGS LIMITED ("ALERE AS HOLDINGS" OR ... FOR AXIS-SHIELD PLC ("AXIS-SHIELD" OR THE ...
... MIAMI and ATLANTA, Sept. 26, 2011 ASTRO Booth ... Oncology (ASTRO) 53rd Annual Meeting, October 2-6 in Miami ... solutions designed to simplify the complex processes involved in ... Elekta technology. "Radiotherapy techniques are becoming ...
Cached Medicine Technology:Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 2Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 3Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 4Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 5Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 6Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 7Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 8Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 9Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 10Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 11Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 12Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 13Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 14Elekta to Demonstrate How its Solutions Foster Confidence in Cancer Management at ASTRO Meeting in Miami 2Elekta to Demonstrate How its Solutions Foster Confidence in Cancer Management at ASTRO Meeting in Miami 3
(Date:7/3/2015)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... and expose popular lies regarding proper relationships according to the bible. , ... the core of the subject by explaining why certain types of sexual relationships are ...
(Date:7/2/2015)... ... ... Enterprises, LLC. is pleased to announce the opening of its newest location in Dallas, Texas. ... premium frozen yogurt chain was listed as #22 on the Inc. 500 list of fastest ... Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX 75220 , ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker Parking Consultants specified ... of Minnesota, they knew it would save the university energy and maintenance costs. ... the total energy savings after installation was an impressive 89 percent, which resulted ...
(Date:7/2/2015)... ... July 02, 2015 , ... “ LIFX ” was featured on NewsWatch ... products available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, ... versatile smart light bulbs on the market. , According to the U.S. Department of ...
(Date:7/2/2015)... ... July 02, 2015 , ... Six months ahead of his 80th birthday, Don ... awareness and money for the Pulmonary Hypertension Association (PHA). Stevenson began the walk ... Washington, D.C. by mid-September. He left Glasgow, Mont. yesterday morning and is making his ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3
... HealthDay Reporter , WEDNESDAY, March 23 (HealthDay News) -- ... unborn babies, Americans, level of exposure to mercury from ... higher risk of heart disease, stroke or other cardiovascular ... prior research that produced inconsistent results, scientists from Harvard ...
... 23 (HealthDay News) -- Exposure to high levels of ... death in lung transplant patients, a new study suggests. ... transplant patients over a five-year period, and found that ... bronchiolitis obliterans syndrome. Of those patients, 61 died. ...
... By Ellin Holohan HealthDay Reporter , WEDNESDAY, ... think they weigh less than they do, and many mothers ... research finds. The study of women and children conducted ... that faulty body image was far more prevalent among the ...
... March 23 (HealthDay News) -- The risk of lung cancer ... that of those who prefer regular cigarettes, researchers report. ... Administration advisory panel that made headlines Friday when it said ... While the panel concluded that menthols, minty flavor seems to ...
... MSc, an assistant professor of medicine at Boston University ... General Internal Medicine,s (SGIM) New England Region 2011 Clinician ... research. The award was presented to Rose at the ... SGIM works to promote research and education that ...
... Why salad helps you say yes to NO , ... the developed world, and can lead to heart attacks, strokes ... bypass surgery and angioplasty, themselves induce vascular injury, after which ... way that limits blood flow. Nitric oxide (NO) is an ...
Cached Medicine News:Health News:Americans' Exposure to Mercury From Fish Won't Harm Hearts: Study 2Health News:Americans' Exposure to Mercury From Fish Won't Harm Hearts: Study 3Health News:High Smog Levels Might Threaten Lung Transplant Success 2Health News:Many Obese Moms and Kids Underestimate Their Weight 2Health News:Many Obese Moms and Kids Underestimate Their Weight 3Health News:Menthol Cigarettes Pose No Added Lung Cancer Risk: Study 2Health News:JCI online early table of contents: March 23, 2011 2Health News:JCI online early table of contents: March 23, 2011 3Health News:JCI online early table of contents: March 23, 2011 4Health News:JCI online early table of contents: March 23, 2011 5Health News:JCI online early table of contents: March 23, 2011 6Health News:JCI online early table of contents: March 23, 2011 7Health News:JCI online early table of contents: March 23, 2011 8Health News:JCI online early table of contents: March 23, 2011 9Health News:JCI online early table of contents: March 23, 2011 10
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: